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Technical Report
Abstract
Purpose: The goal of this study was to improve dosimetry for pelvic, head andneck and other cancers with aspherical planning target volumes (PTV) usingcollimator optimization for intensity modulated radiation therapy (IMRT).
Methods: A retroactive study on the effects of collimator optimization of 20patients was done by comparing collimator angles from optimized plans in Eclipseversion 11.0. Keeping all other parameters equal, plans were created with fourcollimator techniques: CA0, all fields have collimators set to 0°, CAE, using theEclipse collimator optimization, CAA, minimizing the area of the jaws around thePTV, and CAX, minimizing the x-jaw gap. The minimum area and the minimumx-jaw angles were found by evaluating each field beam’s eye view of the PTV with
ImageJ and finding the desired parameters with a custom script. The evaluation ofthe plans included the monitor units (MU), the maximum dose of the plan, themaximum dose to organs at risk (OAR), the conformity index (CI) and the numberof split fields. Results: Compared to the CA0 plans, the monitor units decreased onaverage by 6% for the CAX with a p-value of 0.01 from an ANOVA test. The averagemaximum dose stayed within 1.1% between all four methods with the lowest beingCAX. The maximum dose to the most at risk organ was best spared by the CAA,which decreased by 0.62% from the CA0. Minimizing the x-jaws significantlyreduced the number of split field from 61 to 37. Conclusion: In every field testedthe CAX optimization produced as good or superior results than the other threetechniques. For aspherical PTVs, CAX on average reduced the number of split fields,the maximum dose, minimized the dose to the surrounding OAR, and reduced theMU all while achieving the same control of the PTV.
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1. IntroductionAbout half of all cancer patients undergo radiation atsome point in their treatment.1 Depending on the type ofcancer and severity, roughly half of the patients thatreceive radiation are inversely planned using intensitymodulated radiation therapy (IMRT). In the case ofpelvic, lung and head and neck cancers, the usage ofIMRT becomes more frequent.2, 3 Most of these areplanned with a single collimator angle using a slidingwindow or step-and-shoot technique for delivery.4
Radiation therapy alone or in combination withchemotherapy or surgery offers numerous advantagesover solely chemotherapeutic or surgical treatment ofcancers. Radiation can provide local and targetedtreatment of tumor, therefore decreasing the systemicadverse effects caused by chemotherapy.5 Furthermore,radiation therapy for prostate cancer reducescomplications seen after prostectomy, including erectiledysfunction and urinary incontinence.6 For non-smallcell lung cancer, chemoradiation has been shown to give
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statistically significant benefits in terms of survival ratesthan chemotherapy alone, and allows for treatment inareas of the lung deemed inoperable.7Cancer therapy has been revolutionized with theintroduction of IMRT and multileaf collimators(MLC).8-13 With the use of IMRT, planning can be madeaccurately to conform to the shape of a tumor, helping totreat patients suffering from cancers while minimizingthe dose to surrounding tissue. MLCs are used to shapebeams delivered in IMRT, allowing for an optimal doseto reach the tumor while minimizing the dose tosurrounding areas and organs. The use of IMRT isalready used with large rates of success in sparingnormal tissue and the majority of those are all plannedwith a single collimator angle.14 There could be severalreasons why many dosimetrists avoid using multiplecollimator angles including reducing the length oftreatment delivery, unsure of what angles to use orsimply because they see little or no benefit in therotation. However, there is evidence that collimatorrotation can provide positive effects on a plan and helpto reduce the monitor units (MU), eliminate or minimizethe number of split fields and lower overlappinginterleaf leakage.The goal of this study is to elucidate on conflictingreports about collimator optimization with IMRT.Publications from Chapek et al. showed differences inIMRT collimator rotations with pelvic cases, while otherarticles have stated that the fluence was largelyindependent from collimator angles.15, 16 Using thepresented techniques in collimator optimization tominimize different the x-jaw gap or the area of the jawscan influence the quality of a plan.
2. Methods and Materials
2.1. Programs and TPSAll of the treatments in the present study had beenplanned using Eclipse version 11.0. Patients in the studyhad been treated within the last two years. Thetreatment plans used were all done by traineddosimetrists. The treatment plans in the study were thenreplanned with the four collimator optimizations usingthe same dose constraints and normalizationparameters as the original plan.For the CAA and CAX cases, the values were determinedthrough a script that was created by the authors in
ImageJ. An image of the PTV was taken for each fieldwith the beam’s eye view in Eclipse. A script was writtento analyze using a minimum bounding box at intervals ofone degree of rotation. The values of the box were foundfor the set of possible collimator angles and theminimum parameters for the x-jaw gap and area of thejaws were recorded for CAX and CAA, respectively.
2.2. Patient selectionTwenty patient cases that consisted of pelvic (10), lung(5) and head and neck (5) cancers were studied. Thecriteria for a selected case were that they had alreadybeen treated with an IMRT plan and that the PTV wasgreater than 100 cc and aspherical. Breast patients wereavoided because collimator rotation is routinelyimplemented for such plans. Small lesions weredismissed due to the small number leaves that wouldintersect the radiation field. Spherical PTVs pose theproblem that can lead to a non-unique solution. Patientsselected had been treated on Varian IX, TrueBeam andTrilogy accelerators that use 120 leaves for dosemodulation. All plans were originally created byexperienced dosimetrists and replanned with theoriginal constraints. To keep the plans fair, no fluenceediting was done after the optimization and plans werenormalized to the same value.
Figure 1: A plot of the x-jaw gap vs collimator angle for apelvic field that could split. The program was run to find theminimum value. The angles between 91-270 degrees wereunused to avoid redundancy as well as angle limitations forthe collimator.
Figure 2: The box surrounding the PTV in ImageJ for theminimum area and the minimum x-jaw distance gives theangles for CAA and CAX.
2.3. Method of studyEach patient case was first evaluated for the criteria thatit was planned and approved for treatment using IMRT.Screen captures of the PTV were taken through thebeam’s eye view for each of the fields. The images wererun through the custom script in ImageJ and the results
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of the CAA and CAX were calculated. The optimizationprocess to find the minimum x-jaw gap is graphed inFigure 1. The fields analyze angles between 0 and 90degrees and 271-359 degrees. This allowsaccommodating all possible results without theredundancy angles. Figure 2 shows the jaw positions forthe CAA and CAX for a test field after the minimizationprocess.For the CAE plan, each field was set to optimize thecollimator angle using the Eclipse algorithm to calculatethe ideal angle. The four plans were then set to run in
Eclipse being generated as a new plan through the IMRToptimization. The program was allowed to run tocompletion and each plan was normalized to giveequivalent planning target volume (PTV) coverage as theoriginal plan without editing the fluence. The differencesbetween each test were evaluated with an analysis ofvariance (ANOVA) statistical evaluation comparing eachmethod for the six metrics.
2.4. Plan EvaluationThere were six metrics for which the plans wereevaluated: the total number of monitor units, themaximum dose in the plan, the maximum dose to thetwo most relevant organs at risk, the number of splitfields and the conformality index (CI), which wasdefined using equation (1)
100%
PTV
VCI V . (1)
The total MU measured for each plan is based on a singlefraction of 180 cGy. For evaluation purposes thedifferences from the plans are based on the normalizedCA0 plan. This will render any effects of higherprescriptions to hold the same weight for comparisons.A typical fraction prescription dose for the plans was180 cGy but ranged as high as 1000 cGy for lungstereotactic cases. The maximum dose to the plan ischecked so that it is inside of the PTV. For pelvic cases,the organs at risk (OARs) consisted of the bladder andthe rectum. For lung cases, the OAR varied between theheart, esophagus, spinal cord and contralateral lung. Inthe head and neck patients, the OAR reviewed includedthe parotids, larynx, esophagus, brainstem andmandible. The two highest OAR were taken as OAR1 andOAR2 and normalized between plans for comparison tothe CA0 plan. Split fields were generated automaticallywith the Eclipse optimization when the x-jaw gapexceeded 14.5 cm. Figure 3 shows the setup from thefour optimizations. The CAA has the PTV covered by thejaws due to the field splitting. The subfield matched theline of the jaw to provide the additional coverage of thePTV.
Figure 3: The four configurations for collimator angles are shown for a pelvic case. The field for CAA has the jaws covering theedge of the PTV. A subfield moved the jaws to cover the additional PTV.
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Table 1: A comparison of the six metrics for each modality of collimator optimization.CA0 CAE CAA CAXAvg MU 1376 1350 1385 1293Avg Plan Max Dose 110.09% 110.26% 110.31% 109.83%Avg Max to OAR1 103.47% 103.49% 102.42% 102.94%Avg Max to OAR2 101.48% 102.20% 101.13% 101.22%Avg CI 1.039 1.045 1.037 1.040Total Split Fields 61 63 60 37
Table 2: A one way ANOVA results for each metric. The statistically significant p-values are highlighted and show a reducedMU in CAX compared to CA0 and CAA as well as a decrease in split fields with CAX against all other methods.CA0 vs CAE CA0 vs CAA CA0 vs CAX CAE vs CAX CAE vs CAA CAA vs CAXMonitor Units (MU) 0.20 0.67 0.01 0.31 0.27 0.05Maximum Dose 0.32 0.49 0.56 0.92 0.42 0.37Max to OAR1 0.99 0.79 0.89 0.89 0.78 0.89Max to OAR2 0.87 0.94 0.96 0.81 0.81 0.79Conformality Index 0.88 0.97 0.97 0.91 0.84 0.94Split Fields 0.26 1.00 0.02 0.01 0.84 0.02
3. ResultsThe results of the study are summarized in Table 1. Mostof the parameters showed insignificant changes betweenthe four different techniques. The only optimization thathad statistical significance came from the plans run withCAX, which showed changes in the MU and the splitfields. The results of the ANOVA tests are summarized inTable 2. There was a decrease in MU by 6% on averagefrom the CA0 method and the lowest of the four testedarrangements. A decrease in MU is desirable as it leadsto less radiation time and therefore lower doses ofleaked radiation through the gantry head.The maximum dose on average to the 20 patients waswith the CAX optimization, followed by the CAE. Nomethod offered a statistically significant advantage onaverage, although variations in individual plans areworth noting. A lower value of the maximum dose afteroptimization can help to improve the overall coverage ofthe PTV by allowing more flexibility in the normalizationprocess. Another advantage to the lowered maximumdose in planning occurs when there is an abutting serialorgan, where the dose constraint is often measured bylooking at the maximum dose, such as the spinal cord.The dose at the OAR1 became the lowest by minimizingthe area of the jaws that is exposed to the treatmentfield. The primary OAR in this case was that which wasclosest to the PTV. For the CAA method, covering the
most area with the jaws reduced the maximum dose tothe OAR1 by 1.4% from the CA0 plans. The second lowestwas from the CAX method, which lowered it by about1.0%, although the difference was not enough in eithercase to quantify as statistically significant. The OAR2,which was determined in the plans as the second mostvulnerable organ per patient, was also lowered by thetwo methods, though CAX did slightly better bydecreasing the maximum dose by 1.0% and CAA by 0.6%from the CA0 plans.The confomality index was almost identical for all fourmethods on average at a value of 1.04. All plans werenormalized to the same value per patient. Littledifference and nothing statistically significant werefound for any individual plans for each of the fourmethods, indicating similar V100% volumes regardless ofthe method exercised. A value of 1.00 is desirable,indicating that the volume of the 100% is the same asthe PTV. Although the information that can be derivedfrom the confomality index is limited, it does suggestthat similar tumor control is delivered independentlyfrom collimator angle.Split fields were greatly reduced by using the CAXapproach. In the 20 plans tested, there were nine thatproduced split fields. Since a field will split when theMLC moves more than 14.5 cm due to the limited range
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of the MLC leaves, rotating the jaws to minimize this wasshown to lower the incidence. The number of split fieldsreduced from 61 with CA0 to 36 with CAX. It is worthnoting that CAE increased slightly to 63. At times, the CAE
worked well in reducing the split fields while others itpicked angles that caused a split. Similarly, CAA, whichhad 60, looks for the first minimization as it is knownthat a 90º rotation will give an identical area.
Figure 4: A dose-volume histogram (DVH) of the CA0 and CA¬X plans for a head and neck case. The CAX reduced the dose forthe spinal cord, trachea and carina in large volumes of each OAR.
Figure 5: Fluence models of the four configurations for field. The fluence determines the leaf motion. Higher gradients canlead to more modulation, which can increase the MU and deviations from the planned and delivered treatment.
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Figure 6: A delivered portal dosimetry with four planned collimator methods for a single field. The red areas indicate higherdeviations from the planned and delivered.
Figure 7: The portal dosimetry calculation for a treatment sum with nine fields between the CA0 and CAX. The interleafleakage effects add to give a noticeable difference in the CA0 plan, while rotating the collimator between fields gives a moredesirable distribution.
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4. Discussion and ConclusionIt has been shown that for large (> 100 cc) tumors in thepelvic, head and neck and lung lesions that collimatorrotation can statistically impact a plan. By using a CAXapproach, a planner can decrease the MU and minimizethe number of split fields for a plan. This helps reducethe amount of time a patient is being exposed to leakagefrom the machine and better care for secondary risks.While decreased MU leads to lower radiation time,rotation of the collimator can add time that a patient ison the table. To avoid adding treatment time, rotation ofthe collimator should be less than the gantry angledifferences between fields, since the collimator rotatesslower than then gantry angular speed.While the maximum dose is an important factor inevaluating the risk for an organ, a comprehensive look atthe volume constraints for OAR is necessary fordetermining the safety of a plan. The DVH for a lung casebetween the CAX and CA0 is seen in Figure 4 for thespinal cord, trachea, carina and PTV. The largestdifferences between the methods were observed in thehigher volumes of the organs.While plans may look good on a computer, the actualresults can vary. Figure 5 shows the fluence of a testfield for a pelvic case. High gradient fluence can beincreasingly difficult to model and accurately deliver.Figure 6 shows the same field delivered on an electronicportal imaging device (EPID) and analyzed with portaldosimetry. The red shows differences between theplanned dose with that of the delivered for the fourmethods. Another benefit to collimator rotation betweenfields is shown in Figure 7, which shows the interleafleakage that adds up in the CA0 plan. By rotating thecollimator between fields, the interleaf leakage issmoothed out, which can be seen in the delivered planwith CAX.While determining the angle to minimize the x-jaw gapis often easy to guess based on the geometry, there werecases that the solution was not so obvious. Many casesinvolved pelvic and head and neck cases that had a PTVmeasure close the 14.5 cm threshold for splitting. Asmall deviation from the lowest angle with such a PTVcan cause an unnecessary field split. There is morebenefit in preventing this than just the time for a patientto be treated. The match lines are prone to errors thatare proportional to the slope of the penumbra from thesub-fields. If a patient is slightly out of alignment, anunder or over exposure is the result.
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